FDA has “endangered women and girls by abandoning safeguards for abortion drugs"
Since Roe v. Wade was overturned, chemical abortions now account for over half of all American abortions. What appears to be a convenient procedure is anything but.
According to the FDA, besides killing the most innocent among us, the health risks to the mother can cause heavy bleeding, an incomplete abortion, and infection. According to one report, mifepristone “has been tied to 24 deaths and more than 4,000 adverse events” including a 44% increase in breast cancer risk, a 52% increase in future pre-term births, and a fivefold increase in the risk of suicide. Complications include sepsis, hemorrhage, and undiagnosed ectopic pregnancies that increased by 500%. The FDA also warns that one in 25 women who take abortion drugs will end up in the emergency room.
According to the Alliance Defending Freedom, the FDA has “endangered women and girls by abandoning safeguards for abortion drugs, including in-person visits with a doctor to check for ectopic pregnancies, severe bleeding, and life-threatening infections.”
These dangers are undeniable evidence to end the FDA’s authorization of mifepristone and to enforce the Comstock Act that prohibits its distribution via the U.S. mail. However, the Comstock Act is another relic of the past and like many other laws—never enforced —unless one is defacing a gay pride symbol.